Get all your news in one place.
100's of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

 

Gainers

  • BiondVax Pharmaceuticals (NASDAQ:BVXV) shares moved upwards by 54.72% to $2.29 during Wednesday's pre-market session. The company's market cap stands at $32.8 million.
  • BioRestorative Therapies (NASDAQ:BRTX) stock increased by 38.29% to $6.32. The company's market cap stands at $22.0 million.
  • DBV Technologies (NASDAQ:DBVT) stock increased by 17.26% to $1.63. The market value of their outstanding shares is at $179.2 million.
  • Cocrystal Pharma (NASDAQ:COCP) stock increased by 13.28% to $0.81. The market value of their outstanding shares is at $78.9 million.
  • SenesTech (NASDAQ:SNES) stock increased by 8.73% to $1.12. The company's market cap stands at $13.6 million.
  • Galera Therapeutics (NASDAQ:GRTX) shares moved upwards by 7.7% to $4.75. The market value of their outstanding shares is at $125.5 million.
  •  

Losers

  • Allakos (NASDAQ:ALLK) stock fell 86.47% to $11.42 during Wednesday's pre-market session. The market value of their outstanding shares is at $620.2 million.
  • Statera BioPharma (NASDAQ:STAB) shares declined by 8.49% to $2.05. The company's market cap stands at $65.7 million.
  • Titan Pharmaceuticals (NASDAQ:TTNP) shares declined by 6.88% to $1.22. The company's market cap stands at $12.0 million.
  • PAVmed (NASDAQ:PAVM) stock fell 5.85% to $2.9. The market value of their outstanding shares is at $254.9 million.
  • iSpecimen (NASDAQ:ISPC) shares fell 5.74% to $13.47. The market value of their outstanding shares is at $117.5 million.
  • Quoin Pharmaceuticals (NASDAQ:QNRX) stock decreased by 5.61% to $2.02. The market value of their outstanding shares is at $16.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.